E

Mangoceuticals, Inc. MGRX

$0.44 -$0.04-9.03% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Mangoceuticals, Inc. is a U.S.-based telehealth and wellness company focused on men’s health products, digital health services, and consumer wellness formulations. The company operates primarily in the direct-to-consumer healthcare and nutraceutical sectors, marketing products designed to address erectile dysfunction, hair growth, weight management, testosterone support, and related wellness categories. Mangoceuticals distributes products through online platforms supported by telemedicine consultations and pharmacy fulfillment partnerships, with revenue primarily generated from product sales and subscription-based customer relationships.

The company was founded in 2021 and subsequently became publicly traded on Nasdaq under the ticker MGRX. Its business model emphasizes brand-driven digital marketing, telehealth accessibility, and rapid product commercialization within regulated wellness and pharmaceutical-adjacent markets. Public filings indicate that Mangoceuticals has sought to differentiate itself through flavored and convenience-oriented product formulations, celebrity and influencer marketing strategies, and a focus on younger digitally native consumers seeking discreet healthcare access.

Data compiled by narrative technology. May contain errors.

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)

Price History

Loading...
52-Week Range11% of range
Low
$0.16
Current
$0.44
High
$2.75
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
214 242 9619
Address
17130 N. Dallas Parkway
Suite 240
Dallas, TX 75248
Country
Year Founded

Headlines